This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
FDA to consider new Avastin bids
New study enrols 90% of atrial fibrillation patients at highest risk of stroke
New cancer drugs given NHS go-ahead
New study offers flu vaccine hope
Drug trials “spun to look good”
First patients recruited in new phase III programme
Novartis Phase III failed to meet primary endpoint
Access to cancer drug fund urged
Heartburn drugs fracture warning
FDA extends its review period
Simultaneous vaccines ‘child safe’
Transplant tolerance clues found
« Previous
1
…
65
66
67
68
69
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: